Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Clinical trial NCT06530524 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06530524
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head Neck Cancer Xerostomia Following Radiotherapy

Start date: 2024-10-01
Primary completion: 2026-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.